From: The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
Nafmostat mesilate (n = 201) | Control (n = 106) | Total (N = 307) | P value | |
---|---|---|---|---|
PEP (%) | 35 (17.4) | 11 (10.3) | 46 (15.0) | 0.168 |
Mild (%) | 30 (85.7) | 5 (45.5) | 35 (76.1) | 0.021 |
Moderate to severe (%) | 5 (14.3) | 6 (54.5) | 11 (23.9) |